Sarcoma trials in Austria

6 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Where

  Graz, Vienna

  Age

  18 years and over

  People

  348 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06345729 · EU 2023-507776-42-00
• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  Where

  Feldkirch, Innsbruck, Krems An Der Donau, Linz

  Age

  18 years and over

  People

  400 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07541170 · EU 2025-524263-21-01
• Phase 3Taking people
  International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma

  Where

  Graz, Innsbruck, Linz, Salzburg, Vienna

  Age

  Up to 64 years

  People

  1,351 worldwide

  Run by

  GPOH gGmbH

  See details and how to join2022-501180-40-00 · EU 2022-501180-40-00
• Phase 1Taking people
  International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma

  Where

  Vienna

  People

  18 worldwide

  Run by

  GPOH gGmbH

  See details and how to join2024-515245-42-00 · EU 2024-515245-42-00
• Phase 2/3Taking people
  rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma

  Where

  Graz, Innsbruck, Linz, Salzburg, Vienna

  People

  436 worldwide

  Run by

  The University Of Birmingham

  See details and how to join2024-516078-31-00 · EU 2024-516078-31-00
• Phase 1/2Taking people
  FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

  Where

  Graz, Innsbruck, Linz, Salzburg, Vienna

  People

  1,672 worldwide

  Run by

  University of Birmingham

  See details and how to joinNCT04625907 · EU 2024-510579-40-00